Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month
Acorda Therapeutics today announced that it has launched an INBRIJA® (levodopa inhalation powder) television commercial […]
BioSenic Appoints Lieven Huysse, MD, as Chief Medical Officer (CMO)
BioSenic, the company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces […]
XNK Receives EU Tissue Establishment Certificate
XNK Therapeutics today announced that it has been approved as an EU Tissue Establishment. This […]
NHS Hits Milestone of 200 Children with Hepatitis C Treated in Bid to Stamp Out Virus
Two hundred children in England have now received life-saving treatment for hepatitis C as part […]
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit […]
NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity
NADclinic Group, BioStarks and Do Not Age have joined forces in an exclusive partnership to […]
PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial
PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK on HORIZON, […]
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision […]
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]
Implantica Launches RefluxStop™ in Italy
Implantica, a medtech company at the forefront of bringing advanced technology into the body, announces […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more